BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino, Axel U. Dignass. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s DiseaseJournal of Crohn's and Colitis 2016; 10(8): 873 doi: 10.1093/ecco-jcc/jjw055
2
Renata Curciarello, Guillermo H. Docena, Thomas T. MacDonald. The Role of Cytokines in the Fibrotic Responses in Crohn’s DiseaseFrontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00126
3
Tsutomu Masuda, Naoki Inatsugi, Shusaku Yoshikawa, Hideki Uchida, Hiroyuki Kuge, Tomoyo Yokotani, Kentaro Yamaoka, Mizumi Inagaki, Takayoshi Shimobayashi, Takashi Yokoo, Hidetoshi Nishiwaki. Pyogenic Spondylitis Following Crohn's Disease - A Case ReportNippon Daicho Komonbyo Gakkai Zasshi 2013; 66(7): 504 doi: 10.3862/jcoloproctology.66.504
4
Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort StudyJournal of Crohn's and Colitis 2019; 13(10): 1292 doi: 10.1093/ecco-jcc/jjz057
5
Giovanni Di Nardo, Salvatore Oliva, Maurizio Passariello, Nadia Pallotta, Fortunata Civitelli, Simone Frediani, Gianfranco Gualdi, Paolo Gandullia, Saverio Mallardo, Salvatore Cucchiara. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trialGastrointestinal Endoscopy 2010; 72(6): 1201 doi: 10.1016/j.gie.2010.08.003
6
Emma Calabrese, Christian Maaser, Francesca Zorzi, Klaus Kannengiesser, Stephen B. Hanauer, David H. Bruining, Marietta Iacucci, Giovanni Maconi, Kerri L. Novak, Remo Panaccione, Deike Strobel, Stephanie R. Wilson, Mamoru Watanabe, Francesco Pallone, Subrata Ghosh. Bowel Ultrasonography in the Management of Crohnʼs Disease. A Review with Recommendations of an International Panel of ExpertsInflammatory Bowel Diseases 2016; 22(5): 1168 doi: 10.1097/MIB.0000000000000706
7
Guillaume Bouguen, Laurent Siproudhis, Jean-François Bretagne, Marc-André Bigard, Laurent Peyrin-Biroulet. Nonfistulizing perianal Crohnʼs diseaseInflammatory Bowel Diseases 2010; 16(8): 1431 doi: 10.1002/ibd.21261
8
Amanda B. Muir, Kara Dods, Yuli Noah, Sarit Toltzis, Prasanna Modayur Chandramouleeswaran, Anna Lee, Alain Benitez, Adam Bedenbaugh, Gary W. Falk, Rebecca G. Wells, Hiroshi Nakagawa, Mei-Lun Wang. Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transitionExperimental Cell Research 2015; 330(1): 102 doi: 10.1016/j.yexcr.2014.08.026
9
Shomron Ben-Horin, Niels Vande Casteele, Stefan Schreiber, Peter Laszlo Lakatos. Biosimilars in Inflammatory Bowel Disease: Facts and Fears of ExtrapolationClinical Gastroenterology and Hepatology 2016; 14(12): 1685 doi: 10.1016/j.cgh.2016.05.023
10
Silvio Danese, Stefanos Bonovas, Anthony Lopez, Gionata Fiorino, William J. Sandborn, David T. Rubin, Michael A. Kamm, Jean-Frederic Colombel, Bruce E. Sands, Severine Vermeire, Julian Panes, Gerhard Rogler, Geert D’Haens, Laurent Peyrin-Biroulet. Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s DiseaseGastroenterology 2018; 155(1): 76 doi: 10.1053/j.gastro.2018.03.032
11
Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán. Agentes anti-factor de necrosis tumoral en enfermedad de Crohn y colitis ulcerosa: más allá de la enfermedad luminalGastroenterología y Hepatología 2018; 41(9): 576 doi: 10.1016/j.gastrohep.2018.06.010
12
Mariangela Allocca, Cristiana Bonifacio, Gionata Fiorino, Antonino Spinelli, Federica Furfaro, Luca Balzarini, Stefanos Bonovas, Silvio Danese. Efficacy of tumour necrosis factor antagonists in stricturing Crohn’s disease: A tertiary center real-life experienceDigestive and Liver Disease 2017; 49(8): 872 doi: 10.1016/j.dld.2017.03.012
13
Giovanna Condino, Emma Calabrese, Francesca Zorzi, Sara Onali, Elisabetta Lolli, Fabiola De Biasio, Marta Ascolani, Francesco Pallone, Livia Biancone. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's Disease: A prospective studyDigestive and Liver Disease 2013; 45(3): 258 doi: 10.1016/j.dld.2012.10.009
14
Yoram Bouhnik, Franck Carbonnel, David Laharie, Carmen Stefanescu, Xavier Hébuterne, Vered Abitbol, Maria Nachury, Hedia Brixi, Arnaud Bourreille, Laurence Picon, Anne Bourrier, Matthieu Allez, Laurent Peyrin-Biroulet, Jacques Moreau, Guillaume Savoye, Mathurin Fumery, Stephane Nancey, Xavier Roblin, Romain Altwegg, Guillaume Bouguen, Gilles Bommelaer, Silvio Danese, Edouard Louis, Magaly Zappa, Jean-Yves Mary. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) studyGut 2018; 67(1): 53 doi: 10.1136/gutjnl-2016-312581
15
Brice Malgras, Karine Pautrat, Xavier Dray, Pierre Pasquier, Patrice Valleur, Marc Pocard, Philippe Soyer. Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s DiseaseDigestive Diseases and Sciences 2015; 60(5): 1152 doi: 10.1007/s10620-014-3421-y
16
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli. Safety considerations when using anti-TNFα therapy to treat Crohn’s diseaseExpert Opinion on Drug Safety 2015; 14(1): 31 doi: 10.1517/14740338.2015.976610
17
Lei Lian, Luca Stocchi, Bo Shen, Xiaobo Liu, Jessica Ma, Brook Zhang, Feza Remzi. Prediction of Need for Surgery After Endoscopic Balloon Dilation of Ileocolic Anastomotic Stricture in Patients With Crohn’s DiseaseDiseases of the Colon & Rectum 2015; 58(4): 423 doi: 10.1097/DCR.0000000000000322
18
Sachiko Matsuzaki, Jean-Luc Pouly, Michel Canis. Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor αScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66298-x
19
Cathy Lu, Brandon Baraty, Helen Lee Robertson, Alexis Filyk, Hua Shen, Tak Fung, Kerri Novak, Christopher Ma, Remo Panaccione, Jean-Paul Achkar, Sara El Ouali, David Bruining, Vipul Jairath, Brian Feagan, Florian Rieder. Systematic review: medical therapy for fibrostenosing Crohn’s diseaseAlimentary Pharmacology & Therapeutics 2020; 51(12): 1233 doi: 10.1111/apt.15750
20
W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch. A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel diseaseJournal of Crohn's and Colitis 2010; 4(3): 221 doi: 10.1016/j.crohns.2009.12.001
21
S. M. Sahebally, J. P. Burke, K. H. Chang, M. G. Kiernan, P. R. O'Connell, J. C. Coffey. Circulating fibrocytes and Crohn's diseaseBritish Journal of Surgery 2013; 100(12): 1549 doi: 10.1002/bjs.9302
22
Shishira Bharadwaj, Phillip Fleshner, Bo Shen. Therapeutic Armamentarium for Stricturing Crohnʼs DiseaseInflammatory Bowel Diseases 2015; 21(9): 2194 doi: 10.1097/MIB.0000000000000403
23
Shigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, Teruyuki Takeda, Shin Fujioka, Kento Takenaka, Hiroki Kitamoto, Shotaro Umezawa, Hirotake Sakuraba, Toshihiro Inokuchi, Norimasa Fukata, Shinta Mizuno, Masaki Yamashita, Shinichiro Shinzaki, Hiroki Tanaka, Hidetoshi Takedatsu, Ryo Ozaki, Kei Moriya, Manabu Ishii, Tetsu Kinjo, Keiji Ozeki, Makoto Ooi, Ryohei Hayashi, Kazuki Kakimoto, Yuichi Shimodate, Kazuya Kitamura, Akihiro Yamada, Akira Sonoda, Yu Nishida, Kyouko Yoshioka, Shinya Ashizuka, Fumiaki Takahashi, Toshio Shimokawa, Taku Kobayashi, Akira Andoh, Toshifumi Hibi. A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn’s diseaseJournal of Gastroenterology 2020; 55(6): 615 doi: 10.1007/s00535-020-01670-2
24
Eoin Slattery, Denise Keegan, Diarmuid O'Donoghue. Anorectal stenosis after treatment with tumor necrosis factor α antibodies: a case seriesJournal of Medical Case Reports 2010; 4(1) doi: 10.1186/1752-1947-4-226
25
Naïk Vietti Violi, Alain M. Schoepfer, Nicolas Fournier, Boris Guiu, Pierre Bize, Alban Denys. Prevalence and Clinical Importance of Mesenteric Venous Thrombosis in the Swiss Inflammatory Bowel Disease CohortAmerican Journal of Roentgenology 2014; 203(1): 62 doi: 10.2214/AJR.13.12447
26
Consensus guidelines for the management of inflammatory bowel diseaseArquivos de Gastroenterologia 2010; 47(3): 313 doi: 10.1590/S0004-28032010000300019
27
Florian Rieder, Ellen M Zimmermann, Feza H Remzi, William J Sandborn. Crohn's disease complicated by strictures: a systematic reviewGut 2013; 62(7): 1072 doi: 10.1136/gutjnl-2012-304353
28
Zemin Han, Weiguang Qiao, Xiuyun Ai, Aimin Li, Zhenyu Chen, Jie Zhang, Tianmo Wan, Xicheng Feng, Side Liu, Fachao Zhi. Risk factors for surgery in patients with retention of endoscopic capsuleScandinavian Journal of Gastroenterology 2018; 53(1): 107 doi: 10.1080/00365521.2017.1390603
29
Bo Shen. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications2018; : 249 doi: 10.1016/B978-0-12-811388-2.00022-1
30
Damien Soudan, Yoram Bouhnik. Fibrostenotic Inflammatory Bowel Disease2018; : 209 doi: 10.1007/978-3-319-90578-5_15
31
Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán. Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal diseaseGastroenterología y Hepatología (English Edition) 2018; 41(9): 576 doi: 10.1016/j.gastre.2018.06.014
32
Florian Rieder, Claudio Fiocchi, Gerhard Rogler. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel DiseasesGastroenterology 2017; 152(2): 340 doi: 10.1053/j.gastro.2016.09.047
33
Iago Rodríguez-Lago, Javier P Gisbert. The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn’s DiseaseJournal of Crohn's and Colitis 2020; 14(4): 557 doi: 10.1093/ecco-jcc/jjz158
34
Ferdinando D’Amico, Nicola Pugliese, Laurent Peyrin-Biroulet, Silvio Danese. Efficacy of anti-TNFα drugs in patients with stricturing Crohn’s diseaseExpert Review of Gastroenterology & Hepatology 2020; 14(5): 347 doi: 10.1080/17474124.2020.1759417
35
Jakob Hendel, John Gásdal Karstensen, Peter Vilmann. Serial intralesional injections of infliximab in small bowel Crohn’s strictures are feasible and might lower inflammationUnited European Gastroenterology Journal 2014; 2(5): 406 doi: 10.1177/2050640614547805
36
Ajinkya Ashok Sonambekar, Devendra C Desai, Anand Joshi, Pavan Dhoble. Adalimumab in Crohn's strictures––the CREOLE studyGut 2018; 67(1): 198 doi: 10.1136/gutjnl-2017-314124
37
Cécile Campos, Antoine Perrey, Céline Lambert, Bruno Pereira, Marion Goutte, Anne Dubois, Felix Goutorbe, Michel Dapoigny, Gilles Bommelaer, Constance Hordonneau, Anthony Buisson. Medical Therapies for Stricturing Crohn’s Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic FailureDigestive Diseases and Sciences 2017; 62(6): 1628 doi: 10.1007/s10620-017-4572-4
38
Sara El Ouali, Benjamin Click, Stefan D. Holubar, Florian Rieder. Natural history, diagnosis and treatment approach to fibrostenosing Crohn’s diseaseUnited European Gastroenterology Journal 2020; 8(3): 263 doi: 10.1177/2050640620901960
39
Giovanni Maconi, Elisa Radice, Emilia Bareggi, Gabriele Bianchi Porro. Hydrosonography of the Gastrointestinal TractAmerican Journal of Roentgenology 2009; 193(3): 700 doi: 10.2214/AJR.08.1979